# Clinical Study of Personalized Chemotherapy for Breast Cancer With Low Doses of Cyclophosphamide

> **NCT06361264** · EARLY_PHASE1 · UNKNOWN · sponsor: **KARANAHAN** · enrollment: 20 (estimated)

## Conditions studied

- Stage IV Breast Cancer

## Interventions

- **COMBINATION_PRODUCT:** Karanahan

## Key facts

- **NCT ID:** NCT06361264
- **Lead sponsor:** KARANAHAN
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06361264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06361264, "Clinical Study of Personalized Chemotherapy for Breast Cancer With Low Doses of Cyclophosphamide". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06361264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*